|
|
||||||||
,1



Departments of
* Oncology and
Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel;
Department of Nephrology, Rabin Medical Center, Petach-Tikva, Israel;
Department of Medical Biochemistry, University of Uppsala, The Biomedical Center, Uppsala, Sweden; and
|| Cancer and Vascular Biology Research Center, the Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
2Correspondence: Cancer and Vascular Biology Research Center, Faculty of Medicine, Technion, Haifa 31096, Israel. E-mail: vlodavsk{at}cc.huji.ac.il
We have generated homozygous transgenic mice (hpa-tg) overexpressing human heparanase (endo-ß-D-glucuronidase) in all tissues and characterized the involvement of the enzyme in tissue morphogenesis, vascularization, and energy metabolism. Biochemical analysis of heparan sulfate (HS) isolated from newborn mice and adult tissues revealed a profound decrease in the size of HS chains derived from hpa-tg vs. control mice. Despite this, the mice appeared normal, were fertile, and exhibited a normal life span. A significant increase in the number of implanted embryos was noted in the hpa-tg vs. control mice. Overexpression of heparanase resulted in increased levels of urinary protein and creatinine, suggesting an effect on kidney function, reflected also by electron microscopy examination of the kidney tissue. The hpa-tg mice exhibited a reduced food consumption and body weight compared with control mice. The effect of heparanase on tissue remodeling and morphogenesis was best demonstrated by the phenotype of the hpa-tg mammary glands, showing excess branching and widening of ducts associated with enhanced neovascularization and disruption of the epithelial basement membrane. The hpa-tg mice exhibited an accelerated rate of hair growth, correlated with high expression of heparanase in hair follicle keratinocytes and increased vascularization. Altogether, characterization of the hpa-tg mice emphasizes the involvement of heparanase and HS in processes such as embryonic implantation, food consumption, tissue remodeling, and vascularization.Zcharia, E., Metzger, S., Chajek-Shaul, T., Aingorn, H., Elkin, M., Friedmann, Y., Weinstein, T., Li, J.-P., Lindahl, U., Vlodavsky, I. Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior.
Key Words: transgenic mice mammary glands hair growth implantation heparan sulfate angiogenesis body weight
This article has been cited by other articles:
![]() |
A. B. Baker, A. Groothuis, M. Jonas, D. S. Ettenson, T. Shazly, E. Zcharia, I. Vlodavsky, P. Seifert, and E. R. Edelman Heparanase Alters Arterial Structure, Mechanics, and Repair Following Endovascular Stenting in Mice Circ. Res., February 13, 2009; 104(3): 380 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sandwall, S. Bodevin, N. J. Nasser, E. Nevo, A. Avivi, I. Vlodavsky, and J.-P. Li Molecular Structure of Heparan Sulfate from Spalax: IMPLICATIONS OF HEPARANASE AND HYPOXIA J. Biol. Chem., February 6, 2009; 284(6): 3814 - 3822. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Klipper, E. Tatz, T. Kisliouk, I. Vlodavsky, U. Moallem, D. Schams, Y. Lavon, D. Wolfenson, and R. Meidan Induction of Heparanase in Bovine Granulosa Cells by Luteinizing Hormone: Possible Role during the Ovulatory Process Endocrinology, January 1, 2009; 150(1): 413 - 421. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Bertolesi, G. Michaiel, and S. McFarlane Two Heparanase Splicing Variants with Distinct Properties Are Necessary in Early Xenopus Development J. Biol. Chem., June 6, 2008; 283(23): 16004 - 16016. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Spiegel, E. Zcharia, Y. Vagima, T. Itkin, A. Kalinkovich, A. Dar, O. Kollet, N. Netzer, K. Golan, I. Shafat, et al. Heparanase regulates retention and proliferation of primitive Sca-1+/c-Kit+/Lin- cells via modulation of the bone marrow microenvironment Blood, May 15, 2008; 111(10): 4934 - 4943. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. S. D. Roberts and J. M. Gleadle Familial Nephropathy and Multiple Exostoses With Exostosin-1 (EXT1) Gene Mutation J. Am. Soc. Nephrol., March 1, 2008; 19(3): 450 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. M. Wijnhoven, J. F. M. Lensen, R. G. Wismans, T. G. Hafmans, A. L. W. M. M. Rops, J. van der Vlag, J. H. M. Berden, L. P. W. J. van den Heuvel, and T. H. van Kuppevelt In vivo blockade of sulphated domains of heparan sulphate in the glomerulus does not result in proteinuria Nephrol. Dial. Transplant., February 14, 2008; (2008) gfm690v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S D'Souza, A. T Fazleabas, P. Banerjee, J. R. A Sherwin, A. M Sharkey, M. C Farach-Carson, and D. D Carson Decidual Heparanase Activity Is Increased During Pregnancy in the Baboon (Papio anubis) and in In Vitro Decidualization of Human Stromal Cells Biol Reprod, February 1, 2008; 78(2): 316 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gingis-Velitski, R. Ishai-Michaeli, I. Vlodavsky, and N. Ilan Anti-heparanase monoclonal antibody enhances heparanase enzymatic activity and facilitates wound healing FASEB J, December 1, 2007; 21(14): 3986 - 3993. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J.M. Wijnhoven, J. F.M. Lensen, R. G.P. Wismans, D. J. Lefeber, A. L.W.M.M. Rops, J. van der Vlag, J. H.M. Berden, L. P.W.J. van den Heuvel, and T. H. van Kuppevelt Removal of Heparan Sulfate from the Glomerular Basement Membrane Blocks Protein Passage J. Am. Soc. Nephrol., December 1, 2007; 18(12): 3119 - 3127. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Singh, S. C. Satchell, C. R. Neal, E. A. McKenzie, J. E. Tooke, and P. W. Mathieson Glomerular Endothelial Glycocalyx Constitutes a Barrier to Protein Permeability J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2885 - 2893. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. M. Wijnhoven, J. M. Geelen, M. Bakker, J. F. M. Lensen, A. L. W. M. M. Rops, A. B. Kramer, G. Navis, M. J. W. van den Hoven, J. van der Vlag, J. H. M. Berden, et al. Adult and paediatric patients with minimal change nephrotic syndrome show no major alterations in glomerular expression of sulphated heparan sulphate domains Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2886 - 2893. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S D'Souza, T. Daikoku, M. C Farach-Carson, and D. D Carson Heparanase Expression and Function During Early Pregnancy in Mice Biol Reprod, September 1, 2007; 77(3): 433 - 441. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Fuster, L. Wang, J. Castagnola, L. Sikora, K. Reddi, P. H.A. Lee, K. A. Radek, M. Schuksz, J. R. Bishop, R. L. Gallo, et al. Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis J. Cell Biol., May 7, 2007; 177(3): 539 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yang, V. MacLeod, H.-Q. Miao, A. Theus, F. Zhan, J. D. Shaughnessy Jr., J. Sawyer, J.-P. Li, E. Zcharia, I. Vlodavsky, et al. Heparanase Enhances Syndecan-1 Shedding: A NOVEL MECHANISM FOR STIMULATION OF TUMOR GROWTH AND METASTASIS J. Biol. Chem., May 4, 2007; 282(18): 13326 - 13333. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Xu, J. Ding, G. Rao, J. Shen, R. A. Prinz, N. Rana, and W.P. Dmowski Estradiol induces heparanase-1 expression and heparan sulphate proteoglycan degradation in human endometrium Hum. Reprod., April 1, 2007; 22(4): 927 - 937. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J.M. Wijnhoven, J. F.M. Lensen, R. G.P. Wismans, M. Lamrani, L. A.H. Monnens, R. A. Wevers, A. L.W.M.M. Rops, J. van der Vlag, J. H.M. Berden, L. P.W.J. van den Heuvel, et al. In Vivo Degradation of Heparan Sulfates in the Glomerular Basement Membrane Does Not Result in Proteinuria J. Am. Soc. Nephrol., March 1, 2007; 18(3): 823 - 832. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Harvey and J. H. Miner Breaking Down the Barrier: Evidence against a Role for Heparan Sulfate in Glomerular Permselectivity J. Am. Soc. Nephrol., March 1, 2007; 18(3): 672 - 674. [Full Text] [PDF] |
||||
![]() |
C. Rippe, A. Rippe, A. Larsson, D. Asgeirsson, and B. Rippe Nature of glomerular capillary permeability changes following acute renal ischemia-reperfusion injury in rats Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1362 - F1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ma, S. L. Beck, R. W. Raab, R. L. McKown, G. L. Coffman, A. Utani, W. J. Chirico, A. C. Rapraeger, and G. W. Laurie Heparanase deglycanation of syndecan-1 is required for binding of the epithelial-restricted prosecretory mitogen lacritin J. Cell Biol., September 25, 2006; 174(7): 1097 - 1106. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Edovitsky, I. Lerner, E. Zcharia, T. Peretz, I. Vlodavsky, and M. Elkin Role of endothelial heparanase in delayed-type hypersensitivity Blood, May 1, 2006; 107(9): 3609 - 3616. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Maxhimer, M. Somenek, G. Rao, C. E. Pesce, D. Baldwin Jr., P. Gattuso, M. M. Schwartz, E. J. Lewis, R. A. Prinz, and X. Xu Heparanase-1 Gene Expression and Regulation by High Glucose in Renal Epithelial Cells: A Potential Role in the Pathogenesis of Proteinuria in Diabetic Patients Diabetes, July 1, 2005; 54(7): 2172 - 2178. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Haimov-Kochman, D. Prus, E. Zcharia, D. S. Goldman-Wohl, S. Natanson-Yaron, C. Greenfield, E. Y. Anteby, R. Reich, J. Orly, A. Tsafriri, et al. Spatiotemporal Expression of Heparanase During Human and Rodent Ovarian Folliculogenesis Biol Reprod, July 1, 2005; 73(1): 20 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Levy-Adam, G. Abboud-Jarrous, M. Guerrini, D. Beccati, I. Vlodavsky, and N. Ilan Identification and Characterization of Heparin/Heparan Sulfate Binding Domains of the Endoglycosidase Heparanase J. Biol. Chem., May 27, 2005; 280(21): 20457 - 20466. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Li, M. L. E. Galvis, F. Gong, X. Zhang, E. Zcharia, S. Metzger, I. Vlodavsky, R. Kisilevsky, and U. Lindahl In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis PNAS, May 3, 2005; 102(18): 6473 - 6477. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Horonchik, S. Tzaban, O. Ben-Zaken, Y. Yedidia, A. Rouvinski, D. Papy-Garcia, D. Barritault, I. Vlodavsky, and A. Taraboulos Heparan Sulfate Is a Cellular Receptor for Purified Infectious Prions J. Biol. Chem., April 29, 2005; 280(17): 17062 - 17067. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Zcharia, D. Philp, E. Edovitsky, H. Aingorn, S. Metzger, H. K. Kleinman, I. Vlodavsky, and M. Elkin Heparanase Regulates Murine Hair Growth Am. J. Pathol., April 1, 2005; 166(4): 999 - 1008. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Zcharia, R. Zilka, A. Yaar, O. Yacoby-Zeevi, A. Zetser, S. Metzger, R. Sarid, A. Naggi, B. Casu, N. Ilan, et al. Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models FASEB J, February 1, 2005; 19(2): 211 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yang, V. MacLeod, M. Bendre, Y. Huang, A. M. Theus, H.-Q. Miao, P. Kussie, S. Yaccoby, J. Epstein, L. J. Suva, et al. Heparanase promotes the spontaneous metastasis of myeloma cells to bone Blood, February 1, 2005; 105(3): 1303 - 1309. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Levidiotis, C. Freeman, M. Punler, P. Martinello, B. Creese, V. Ferro, J. van der Vlag, J. H.M. Berden, C. R. Parish, and D. A. Power A Synthetic Heparanase Inhibitor Reduces Proteinuria in Passive Heymann Nephritis J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2882 - 2892. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Edovitsky, M. Elkin, E. Zcharia, T. Peretz, and I. Vlodavsky Heparanase Gene Silencing, Tumor Invasiveness, Angiogenesis, and Metastasis J Natl Cancer Inst, August 18, 2004; 96(16): 1219 - 1230. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |